Welcome to LookChem.com Sign In|Join Free

CAS

  • or

917396-30-6

3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine is a complex organic chemical compound characterized by a pyridine ring structure. This molecule features a bromine atom attached to a methyl group at the 3rd position, a methyl group at the 2nd position, and a trifluoromethyl group at the 6th position. The compound is known for its potential applications in the synthesis of pharmaceuticals and agrochemicals due to its unique structure and reactivity. It is a colorless to pale yellow liquid with a molecular formula of C8H7BrF3N and a molecular weight of 268.05 g/mol. The presence of the bromine atom makes it a valuable intermediate for further chemical reactions, while the trifluoromethyl group imparts specific properties that can be exploited in various chemical processes.

917396-30-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 917396-30-6 Structure

  • Basic information

    1. Product Name: 3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine
    2. Synonyms: 3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine
    3. CAS NO:917396-30-6
    4. Molecular Formula: C8H7BrF3N
    5. Molecular Weight: 254.0470896
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 917396-30-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 225.4±35.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.568±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 0.35±0.22(Predicted)
    10. CAS DataBase Reference: 3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine(917396-30-6)
    12. EPA Substance Registry System: 3-(Bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine(917396-30-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 917396-30-6(Hazardous Substances Data)

917396-30-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 917396-30-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,3,9 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 917396-30:
(8*9)+(7*1)+(6*7)+(5*3)+(4*9)+(3*6)+(2*3)+(1*0)=196
196 % 10 = 6
So 917396-30-6 is a valid CAS Registry Number.

917396-30-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(bromomethyl)-2-methyl-6-(trifluoromethyl)pyridine

1.2 Other means of identification

Product number -
Other names 3-Bromomethyl-2-methyl-6-trifluoromethylpyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:917396-30-6 SDS

917396-30-6Relevant articles and documents

Triazolopyridine cannabinoid receptor 1 antagonists

-

Page/Page column 78, (2008/06/13)

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.

Triazolopyrimidine cannabinoid receptor 1 antagonists

-

Page/Page column 43, (2010/11/25)

The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formulas I and II both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 917396-30-6